SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-071297
Filing Date
2023-03-15
Accepted
2023-03-15 16:05:49
Documents
4
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 6-K d471204d6k.htm 6-K 9437
2 EX-99.1 d471204dex991.htm EX-99.1 12784
3 GRAPHIC g471204g0315010240987.jpg GRAPHIC 3763
4 GRAPHIC g471204g0315010241112.jpg GRAPHIC 2881
  Complete submission text file 0001193125-23-071297.txt   32880
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 23735181
SIC: 2834 Pharmaceutical Preparations